190 related articles for article (PubMed ID: 35987730)
21. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
22. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
23. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
[TBL] [Abstract][Full Text] [Related]
24. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract][Full Text] [Related]
25. Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma.
Shao Y; Xiong S; Sun G; Dou W; Hu X; Yang W; Lia T; Deng S; Wei Q; Zeng H; Li X
Cancer Med; 2020 Feb; 9(3):959-970. PubMed ID: 31840431
[TBL] [Abstract][Full Text] [Related]
26. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
[TBL] [Abstract][Full Text] [Related]
27. Textural differences between renal cell carcinoma subtypes: Machine learning-based quantitative computed tomography texture analysis with independent external validation.
Kocak B; Yardimci AH; Bektas CT; Turkcanoglu MH; Erdim C; Yucetas U; Koca SB; Kilickesmez O
Eur J Radiol; 2018 Oct; 107():149-157. PubMed ID: 30292260
[TBL] [Abstract][Full Text] [Related]
28. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma.
Guo P; Wang Y; Han Y; Wei D; Zhao J; Li M; Jiang Y; Luo Y
Urol Oncol; 2021 Dec; 39(12):835.e19-835.e27. PubMed ID: 34620554
[TBL] [Abstract][Full Text] [Related]
30. Clear Cell Renal Cell Carcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis for Prediction of Fuhrman Nuclear Grade.
Bektas CT; Kocak B; Yardimci AH; Turkcanoglu MH; Yucetas U; Koca SB; Erdim C; Kilickesmez O
Eur Radiol; 2019 Mar; 29(3):1153-1163. PubMed ID: 30167812
[TBL] [Abstract][Full Text] [Related]
31. Comparison of time-to-event machine learning models in predicting oral cavity cancer prognosis.
Adeoye J; Hui L; Koohi-Moghadam M; Tan JY; Choi SW; Thomson P
Int J Med Inform; 2022 Jan; 157():104635. PubMed ID: 34800847
[TBL] [Abstract][Full Text] [Related]
32. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.
Parker WP; Cheville JC; Frank I; Zaid HB; Lohse CM; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2017 Apr; 71(4):665-673. PubMed ID: 27287995
[TBL] [Abstract][Full Text] [Related]
33. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
34. Machine Learning Did Not Outperform Conventional Competing Risk Modeling to Predict Revision Arthroplasty.
Oosterhoff JHF; de Hond AAH; Peters RM; van Steenbergen LN; Sorel JC; Zijlstra WP; Poolman RW; Ring D; Jutte PC; Kerkhoffs GMMJ; Putter H; Steyerberg EW; Doornberg JN;
Clin Orthop Relat Res; 2024 Mar; ():. PubMed ID: 38470976
[TBL] [Abstract][Full Text] [Related]
35. A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning.
Wang Z; Xu C; Liu W; Zhang M; Zou J; Shao M; Feng X; Yang Q; Li W; Shi X; Zang G; Yin C
Front Endocrinol (Lausanne); 2022; 13():1083569. PubMed ID: 36686417
[TBL] [Abstract][Full Text] [Related]
36. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
[TBL] [Abstract][Full Text] [Related]
37. Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection.
Zeng J; Zeng J; Lin K; Lin H; Wu Q; Guo P; Zhou W; Liu J
Hepatobiliary Surg Nutr; 2022 Apr; 11(2):176-187. PubMed ID: 35464276
[TBL] [Abstract][Full Text] [Related]
38. Using machine learning to predict lymph node metastasis in patients with renal cell carcinoma: A population-based study.
Zhang Y; Yi X; Tang Z; Xie P; Yin N; Deng Q; Zhu L; Luo H; Peng K
Front Public Health; 2023; 11():1104931. PubMed ID: 37033061
[TBL] [Abstract][Full Text] [Related]
39. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
40. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
